Cue Biopharma (STU:1UC) Total Stockholders Equity : €27.64 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cue Biopharma Total Stockholders Equity?

Cue Biopharma's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €27.64 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cue Biopharma's Book Value per Share for the quarter that ended in Mar. 2024 was €0.57. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cue Biopharma's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.43.

Cue Biopharma Total Stockholders Equity Historical Data

The historical data trend for Cue Biopharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cue Biopharma Total Stockholders Equity Chart

Cue Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

49.13

64.87

57.96

62.00

34.01

Cue Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															51.39	42.46	39.98	34.01	27.64

Cue Biopharma (STU:1UC) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cue Biopharma's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(27.635	-	0)	/	48.6433
	=	0.57

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cue Biopharma's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.599	+	5.357)	/	27.635
	=	0.43

Cue Biopharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cue Biopharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cue Biopharma (STU:1UC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cue Biopharma Inc (STU:1UC) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

CUE:USA

Address

40 Guest Street, Boston, MA, USA, 02135

Website

https://www.cuebiopharma.com

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401.

Cue Biopharma (STU:1UC) Headlines

No Headlines